MAP2K1 and neoplasm: Comprehensive genomic profiling of the formalin fixed the tumor tissue, and the cryopreserved leukemic cells revealed several common alterations and divergent clonal evolution with a novel <i>MAP2K1</i> mutation of the IDCS, which is responsible for the trans-differentiation of the common lymphoid-committed tumor progenitor.